Tafamidis

Wool heart
Favicon Fierce Biotech

Don't count out Alnylam's next-gen silencer in ATTR-CM: analysts

Patients' disease stage, transthyretin knockdown levels and trial design have become focal points in debates around silencer-stabilizer combos.
Gavel and scale

Pfizer fends off generic Vyndamax entry until 2031

Apr 28, 2026 4:30pm
settlement

Pfizer inks settlements with 2 generic Vyndamax contenders

Apr 27, 2026 11:23am
Magnifying glass amplifying warning sign over falling stock figures

BridgeBio shares slide on Pfizer's ATTR patent withdrawal

Feb 6, 2026 10:50am
Rocket with heart on blue background

Is Pfizer's recent ATTR sales decline in the US a warning sign?

Dec 2, 2025 8:20am
Pfizer

Pfizer to discontinue low-dose ATTR drug Vyndaqel in US in 2025

Aug 29, 2025 10:40am